10x Genomics Inc - Ordinary Shares - Class A

NASDAQ:TXG   12:31:55 PM EDT
-4.85 (-5.12%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)10.03B
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$148.66 Million
Adjusted EPS-$0.09
See more estimates
10-Day MA$100.67
50-Day MA$135.91
200-Day MA$163.32
See more pivots

10x Genomics Inc - Ordinary Shares - Class A Stock, NASDAQ:TXG

6230 Stoneridge Mall Road, Pleasanton, California 94588
United States of America
Phone: +1.925.401.7300
Number of Employees: 852


10X Genomics, Inc. is a life science technology company, which engages in building products to interrogate, understand and master biology. Its integrated solutions include single cell transcriptomics, single cell genomics, single cell epigenomes, linked-reads genomics and spatial transcriptomics. The companyâ??s products include Single Cell Gene Expression, Immune Profiling, CNV, ATAC, and Genome and Exome. 10X Genomics was founded by Serge Saxonov, Ben Hindson and Kevin D. Ness on July 2, 2012 and is headquartered in Pleasanton, CA.